Polymorphisms in RAS/RAF/MEK/ERK Pathway Are Associated with Gastric Cancer

Overview

Journal Genes (Basel)

Publisher MDPI

Date 2019 Jan 2

PMID 30597917

Citations 14

Authors

Patricio Gonzalez-Hormazabal

Maher Musleh

Marco Bustamante

Juan Stambuk

Raul Pisano

Hector Valladares

Enrique Lanzarini

Hector Chiong

Jorge Rojas

Jose Suazo

V Gonzalo Castro

Lilian Jara

Zoltan Berger

Affiliations

Soon will be listed here.

Abstract

The RAS/RAF/MEK/ERK pathway regulates certain cellular functions, including cell proliferation, differentiation, survival, and apoptosis. Dysregulation of this pathway leads to the occurrence and progression of cancers mainly by somatic mutations. This study aimed to assess if polymorphisms of the RAS/RAF/MEK/ERK pathway are associated with gastric cancer. A case-control study of 242 gastric cancer patients and 242 controls was performed to assess the association of 27 single nucleotide polymorphisms (SNPs) in the RAS/RAF/MEK/ERK pathway genes with gastric cancer. Analyses performed under the additive model (allele) showed four significantly associated SNPs: rs3729931 (Odds ratio (OR) = 1.54, 95%, confidence interval (CI): 1.20⁻1.98, -value = 7.95 × 10), rs45604736 (OR = 1.60, 95% CI: 1.16⁻2.22, -value = 4.68 × 10), rs2283792 (OR = 1.45, 95% CI: 1.12⁻1.87, -value = 4.91 × 10), and rs9610417 (OR = 0.60, 95% CI: 0.42⁻0.87, -value = 6.64 × 10). Functional annotation suggested that those variants or their proxy variants may have a functional effect. In conclusion, this study suggests that rs3729931, rs45604736, rs2283792, and rs9610417 are associated with gastric cancer.

Citing Articles

Design, Synthesis, and Anti-Leukemic Evaluation of a Series of Dianilinopyrimidines by Regulating the Ras/Raf/MEK/ERK and STAT3/c-Myc Pathways.

Wang C, Wang B, Mou Y, Liu X, Chen Q, Pu W Molecules. 2024; 29(7).

PMID: 38611876 PMC: 11013136. DOI: 10.3390/molecules29071597.

Targeting PI3K/AKT/mTOR and MAPK Signaling Pathways in Gastric Cancer.

Morgos D, Stefani C, Miricescu D, Greabu M, Stanciu S, Nica S Int J Mol Sci. 2024; 25(3).

PMID: 38339127 PMC: 10856016. DOI: 10.3390/ijms25031848.

COVID-19: A Possible Contribution of the MAPK Pathway.

Cusato J, Manca A, Palermiti A, Mula J, Costanzo M, Antonucci M Biomedicines. 2023; 11(5).

PMID: 37239131 PMC: 10216575. DOI: 10.3390/biomedicines11051459.

Mutational landscape of gastric adenocarcinoma in Latin America: A genetic approach for precision medicine.

Cerrato-Izaguirre D, Chirino Y, Garcia-Cuellar C, Santibanez-Andrade M, Prada D, Hernandez-Guerrero A Genes Dis. 2022; 9(4):928-940.

PMID: 35685475 PMC: 9170608. DOI: 10.1016/j.gendis.2021.04.002.

Quantification of the Landscape for Revealing the Underlying Mechanism of Intestinal-Type Gastric Cancer.

Yu C, Wang J Front Oncol. 2022; 12:853768.

PMID: 35592672 PMC: 9110827. DOI: 10.3389/fonc.2022.853768.

References

Greenman C, Stephens P, Smith R, Dalgliesh G, Hunter C, Bignell G . Patterns of somatic mutation in human cancer genomes. Nature. 2007; 446(7132):153-8. PMC: 2712719. DOI: 10.1038/nature05610. View

Zhang Y, Jin M, Liu B, Ma X, Yao K, Li Q . Association between H-RAS T81C genetic polymorphism and gastrointestinal cancer risk: a population based case-control study in China. BMC Cancer. 2008; 8:256. PMC: 2546424. DOI: 10.1186/1471-2407-8-256. View

Price A, Zaitlen N, Reich D, Patterson N . New approaches to population stratification in genome-wide association studies. Nat Rev Genet. 2010; 11(7):459-63. PMC: 2975875. DOI: 10.1038/nrg2813. View

Lemmon M, Schlessinger J . Cell signaling by receptor tyrosine kinases. Cell. 2010; 141(7):1117-34. PMC: 2914105. DOI: 10.1016/j.cell.2010.06.011. View

Anderson C, Pettersson F, Clarke G, Cardon L, Morris A, Zondervan K . Data quality control in genetic case-control association studies. Nat Protoc. 2010; 5(9):1564-73. PMC: 3025522. DOI: 10.1038/nprot.2010.116. View

Parsa A, Chang Y, Kelly R, Corretti M, Ryan K, Robinson S . Hypertrophy-associated polymorphisms ascertained in a founder cohort applied to heart failure risk and mortality. Clin Transl Sci. 2011; 4(1):17-23. PMC: 4373555. DOI: 10.1111/j.1752-8062.2010.00251.x. View

Ernst J, Kheradpour P, Mikkelsen T, Shoresh N, Ward L, Epstein C . Mapping and analysis of chromatin state dynamics in nine human cell types. Nature. 2011; 473(7345):43-9. PMC: 3088773. DOI: 10.1038/nature09906. View

Ruschoff J, Hanna W, Bilous M, Hofmann M, Osamura R, Penault-Llorca F . HER2 testing in gastric cancer: a practical approach. Mod Pathol. 2012; 25(5):637-50. DOI: 10.1038/modpathol.2011.198. View

De Luca A, Maiello M, DAlessio A, Pergameno M, Normanno N . The RAS/RAF/MEK/ERK and the PI3K/AKT signalling pathways: role in cancer pathogenesis and implications for therapeutic approaches. Expert Opin Ther Targets. 2012; 16 Suppl 2:S17-27. DOI: 10.1517/14728222.2011.639361. View

10.

Pirinen M, Donnelly P, Spencer C . Including known covariates can reduce power to detect genetic effects in case-control studies. Nat Genet. 2012; 44(8):848-51. DOI: 10.1038/ng.2346. View

11.

Schaub M, Boyle A, Kundaje A, Batzoglou S, Snyder M . Linking disease associations with regulatory information in the human genome. Genome Res. 2012; 22(9):1748-59. PMC: 3431491. DOI: 10.1101/gr.136127.111. View

12.

Boyle A, Hong E, Hariharan M, Cheng Y, Schaub M, Kasowski M . Annotation of functional variation in personal genomes using RegulomeDB. Genome Res. 2012; 22(9):1790-7. PMC: 3431494. DOI: 10.1101/gr.137323.112. View

13.

Guggenheim D, Shah M . Gastric cancer epidemiology and risk factors. J Surg Oncol. 2012; 107(3):230-6. DOI: 10.1002/jso.23262. View

14.

Chomczynski P, Sacchi N . Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem. 1987; 162(1):156-9. DOI: 10.1006/abio.1987.9999. View

15.

. Comprehensive molecular characterization of gastric adenocarcinoma. Nature. 2014; 513(7517):202-9. PMC: 4170219. DOI: 10.1038/nature13480. View

16.

Wong S, Kim K, Ting J, Yu K, Fu J, Liu S . Genomic landscape and genetic heterogeneity in gastric adenocarcinoma revealed by whole-genome sequencing. Nat Commun. 2014; 5:5477. DOI: 10.1038/ncomms6477. View

17.

Samatar A, Poulikakos P . Targeting RAS-ERK signalling in cancer: promises and challenges. Nat Rev Drug Discov. 2014; 13(12):928-42. DOI: 10.1038/nrd4281. View

18.

Mocellin S, Verdi D, Pooley K, Nitti D . Genetic variation and gastric cancer risk: a field synopsis and meta-analysis. Gut. 2015; 64(8):1209-19. DOI: 10.1136/gutjnl-2015-309168. View

19.

Kratz C, Franke L, Peters H, Kohlschmidt N, Kazmierczak B, Finckh U . Cancer spectrum and frequency among children with Noonan, Costello, and cardio-facio-cutaneous syndromes. Br J Cancer. 2015; 112(8):1392-7. PMC: 4402457. DOI: 10.1038/bjc.2015.75. View

20.

Cristescu R, Lee J, Nebozhyn M, Kim K, Ting J, Wong S . Molecular analysis of gastric cancer identifies subtypes associated with distinct clinical outcomes. Nat Med. 2015; 21(5):449-56. DOI: 10.1038/nm.3850. View